A detailed history of Compass Capital Corp /Ma/ /Adv transactions in Amgen Inc stock. As of the latest transaction made, Compass Capital Corp /Ma/ /Adv holds 885 shares of AMGN stock, worth $255,375. This represents 0.13% of its overall portfolio holdings.

Number of Shares
885
Previous 870 1.72%
Holding current value
$255,375
Previous $227 Million 5.97%
% of portfolio
0.13%
Previous 0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 21, 2025

BUY
$258.59 - $327.36 $3,878 - $4,910
15 Added 1.72%
885 $240 Million
Q4 2024

Feb 03, 2025

BUY
$258.78 - $328.31 $225,138 - $285,629
870 New
870 $227 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Compass Capital Corp /Ma/ /Adv Portfolio

Follow Compass Capital Corp /Ma/ /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compass Capital Corp /Ma/ /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Compass Capital Corp /Ma/ /Adv with notifications on news.